Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1994 2
1995 2
1996 1
1997 2
2003 1
2005 3
2006 1
2008 2
2009 2
2010 3
2011 1
2012 2
2013 5
2014 1
2015 7
2016 6
2017 4
2018 1
2019 6
2020 10
2021 10
2022 7
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer.
Turner NC, Ro J, André F, Loi S, Verma S, Iwata H, Harbeck N, Loibl S, Huang Bartlett C, Zhang K, Giorgetti C, Randolph S, Koehler M, Cristofanilli M; PALOMA3 Study Group. Turner NC, et al. N Engl J Med. 2015 Jul 16;373(3):209-19. doi: 10.1056/NEJMoa1505270. Epub 2015 Jun 1. N Engl J Med. 2015. PMID: 26030518 Free article. Clinical Trial.
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study.
Harbeck N, Rastogi P, Martin M, Tolaney SM, Shao ZM, Fasching PA, Huang CS, Jaliffe GG, Tryakin A, Goetz MP, Rugo HS, Senkus E, Testa L, Andersson M, Tamura K, Del Mastro L, Steger GG, Kreipe H, Hegg R, Sohn J, Guarneri V, Cortés J, Hamilton E, André V, Wei R, Barriga S, Sherwood S, Forrester T, Munoz M, Shahir A, San Antonio B, Nabinger SC, Toi M, Johnston SRD, O'Shaughnessy J; monarchE Committee Members. Harbeck N, et al. Ann Oncol. 2021 Dec;32(12):1571-1581. doi: 10.1016/j.annonc.2021.09.015. Epub 2021 Oct 14. Ann Oncol. 2021. PMID: 34656740 Free article. Clinical Trial.
Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization.
Wang TY, Wahed AS, Morris A, Kreuziger LB, Quigley JG, Lamas GA, Weissman AJ, Lopez-Sendon J, Knudson MM, Siegal DM, Kasthuri RS, Alexander AJ, Wahid L, Atassi B, Miller PJ, Lawson JW, Patel B, Krishnan JA, Shapiro NL, Martin DE, Kindzelski AL, Leifer ES, Joo J, Lyu L, Pennella A, Everett BM, Geraci MW, Anstrom KJ, Ortel TL; ACTIV-4C Study Group. Wang TY, et al. Ann Intern Med. 2023 Apr;176(4):515-523. doi: 10.7326/M22-3350. Epub 2023 Mar 21. Ann Intern Med. 2023. PMID: 36940444 Free PMC article. Clinical Trial.
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
Coombes RC, Howell S, Lord SR, Kenny L, Mansi J, Mitri Z, Palmieri C, Chap LI, Richards P, Gradishar W, Sardesai S, Melear J, O'Shaughnessy J, Ward P, Chalasani P, Arkenau T, Baird RD, Jeselsohn R, Ali S, Clack G, Bahl A, McIntosh S, Krebs MG. Coombes RC, et al. Among authors: chalasani p. Nat Commun. 2023 Jul 24;14(1):4444. doi: 10.1038/s41467-023-40061-y. Nat Commun. 2023. PMID: 37488191 Free PMC article. Clinical Trial.
Safety and Tolerability of a Novel Anti-HER2 Antibody-Drug Conjugate (PF-06804103) in Patients with HER2-Expressing Solid Tumors: A Phase 1 Dose-Escalation Study.
Meric-Bernstam F, Calvo E, Lee KS, Moreno V, Park YH, Rha SY, Chalasani P, Zhong W, Zhou L, Pirie-Shepherd S, Leung ACF, Curigliano G. Meric-Bernstam F, et al. Among authors: chalasani p. Mol Cancer Ther. 2023 Oct 2;22(10):1191-1203. doi: 10.1158/1535-7163.MCT-23-0101. Mol Cancer Ther. 2023. PMID: 37420274 Free PMC article. Clinical Trial.
Spontaneous Paraesophageal Hematoma.
Yan J, Walker C, Chalasani P. Yan J, et al. Among authors: chalasani p. ACG Case Rep J. 2015 Oct 9;3(1):29-30. doi: 10.14309/crj.2015.91. eCollection 2015 Oct. ACG Case Rep J. 2015. PMID: 26504872 Free PMC article.
Transcranial Magnetic Stimulation for the Treatment of Chemo Brain.
Kuo PH, Chen AY, Rodriguez RJ, Stuehm C, Chalasani P, Chen NK, Chou YH. Kuo PH, et al. Among authors: chalasani p. Sensors (Basel). 2023 Sep 22;23(19):8017. doi: 10.3390/s23198017. Sensors (Basel). 2023. PMID: 37836847 Free PMC article. Clinical Trial.
Triple Threat: Triple Pathogen Endocarditis.
Gonzalez JM, Lowenhaar G, Ramgopal M, Chalasani P. Gonzalez JM, et al. Among authors: chalasani p. Cureus. 2023 Oct 28;15(10):e47860. doi: 10.7759/cureus.47860. eCollection 2023 Oct. Cureus. 2023. PMID: 38021926 Free PMC article.
Nuclear epidermal growth factor receptor as a therapeutic target.
Atwell B, Chalasani P, Schroeder J. Atwell B, et al. Among authors: chalasani p. Explor Target Antitumor Ther. 2023;4(4):616-629. doi: 10.37349/etat.2023.00156. Epub 2023 Aug 30. Explor Target Antitumor Ther. 2023. PMID: 37720348 Free PMC article. Review.
Left ventricular puncture during thoracentesis.
Farinas Lugo D, Chalasani P, Del Calvo V. Farinas Lugo D, et al. Among authors: chalasani p. BMJ Case Rep. 2019 Apr 8;12(4):e227613. doi: 10.1136/bcr-2018-227613. BMJ Case Rep. 2019. PMID: 30967447 Free PMC article.
88 results